Johnson & Johnson vs SoFi Technologies Inc — how do they compare? Johnson & Johnson trades at $261.07 (market cap $626.09B), while SoFi Technologies Inc trades at $17.85 (market cap $23.22B). The key difference: Johnson & Johnson is far larger — about 27× SoFi Technologies Inc's market cap, and Johnson & Johnson pays a 2.06% dividend while SoFi Technologies Inc pays none. Which is the better fit depends on your goals.
| JNJ | SOFI | |
|---|---|---|
Market Cap | $626.09B | $23.22B |
Volume | 6,156,228 | — |
Sector | Health | Financials |
52-Week High | $267.24 | $32.21 |
52-Week Low | $172.78 | $15.15 |
Enterprise Value | $654.37B | — |
Dividend Yield | 2.06% | — |
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.
Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.
SoFi Technologies (SOFI) trades at $17.82, down 1.66% on the day, with a bullish technical signal from moving averages despite a neutral RSI. The company reported strong Q2 2026 earnings, beating EPS estimates with 40% year-over-year adjusted net revenue growth and record loan originations. Revenue guidance for 2026 was raised to $4.75-$4.85 billion. The stock's valuation shows a P/E of 36.69 and P/S of 5.6, reflecting growth expectations. Analyst consensus is a 'Buy' with a $19.50 price target, though institutional sentiment is mixed with recent position adjustments.
The outlook for SOFI is positive, driven by robust member growth, cross-selling success, and expanding fee-based revenue. Key risks include dependence on interest rate trends, competitive pressures in digital banking, and execution challenges in scaling the technology platform. The stock presents an opportunity for growth investors, but volatility may persist amid macroeconomic uncertainties and investor sensitivity to guidance updates.
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →